The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.

[1]  E. Bateman,et al.  Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis. , 2015, The Journal of allergy and clinical immunology.

[2]  E. Bleecker,et al.  Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials. , 2015, The Lancet. Respiratory medicine.

[3]  S. Korn,et al.  Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma , 2014, Respiratory Research.

[4]  E. R. Sutherland,et al.  Predictors of response to tiotropium versus salmeterol in asthmatic adults. , 2013, The Journal of allergy and clinical immunology.

[5]  E. Bleecker,et al.  Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate , 2013 .

[6]  Michael Engel,et al.  Tiotropium in asthma poorly controlled with standard combination therapy. , 2012, The New England journal of medicine.

[7]  H. Kerstjens,et al.  Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. , 2011, The Journal of allergy and clinical immunology.

[8]  E. Bateman,et al.  Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. , 2011, The Journal of allergy and clinical immunology.

[9]  E. R. Sutherland,et al.  Tiotropium bromide step-up therapy for adults with uncontrolled asthma. , 2010, The New England journal of medicine.

[10]  H. Ortega,et al.  Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma. , 2010, Respiratory medicine.

[11]  Toshiyuki Yamagata,et al.  The Strategy for Predicting Future Exacerbation of Asthma Using a Combination of the Asthma Control Test and Lung Function Test , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  L. Boulet,et al.  Suboptimal asthma control: prevalence, detection and consequences in general practice , 2008, European Respiratory Journal.

[13]  W. Busse,et al.  Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. , 2007, The Journal of allergy and clinical immunology.

[14]  W. Busse,et al.  Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study , 2006, BMC pulmonary medicine.

[15]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[16]  A Tattersfield,et al.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. , 2001, American journal of respiratory and critical care medicine.

[17]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[18]  P. Ind,et al.  Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid , 1994, The Lancet.